Search

everythinglearnresearchcommunity

for

Search:↓

Some people experienced hair loss after COVID-19 vaccination, but it's very rare and vaccines' benefits are greater than this risk.

COVID-19 can cause hair loss due to stress, with inflammation markers like D-dimer levels playing a role.

Weight loss can cause temporary hair loss, especially in women and older adults.

COVID-19 may worsen hair loss, and Nourkrin® could be a safe treatment option, but more research is needed.

A botanical extract may help manage hair loss from chemotherapy by preventing cell death in hair follicles.

People with chronic hair loss often have lower Vitamin B12 levels.

COVID-19 can cause hair loss, and treatments like PRP and stem cells might help.

Different methods, including stress management, healthy diet, supplements, and treatments like minoxidil, can help hair grow back after COVID-19 related hair loss.

Anemia increases the risk of hair loss in post-COVID-19 survivors.

Hair loss after bariatric surgery is common due to nutrient deficiencies and rapid weight loss.

The treatment improved hair growth and thickness in patients with hair loss, even 10 months after therapy without additional products.

Sorafenib may cause hair loss in a way similar to alopecia areata.

Chemotherapy causes hair loss by damaging hair follicles and stem cells, with more research needed for prevention and treatment.

The conclusion is that treatments for Telogen Effluvium exist, but standard treatment guidelines are needed.

Indian dermatologists recommend treating common hair loss with a balanced diet, stress reduction, mild shampoos, and sometimes minoxidil and supplements.

Many COVID-19 patients experience temporary hair loss after infection, not linked to infection severity or treatment.

ALRV5XR significantly improves hair density in women with hair loss and is well-tolerated.

Certain growth factors significantly affect hair loss in women with telogen effluvium.

A man had temporary hair loss from radiation during a medical procedure but regrew his hair after treatment with minoxidil lotion.

The balance of thiol-disulfide in women with hair loss is affected but not damaged.

A woman with low thyroid function did not lose her hair during chemotherapy, possibly because her hair follicles were less affected by the treatment.

A 17-year-old girl had severe, on-and-off hair loss, likely due to COVID-19. She was treated with Vitamin D3, biotin, and other supplements, and saw some improvement within a month.

A critically ill boy experienced hair loss likely due to the stress of his medical treatments, but his hair regrew completely in 1.5 months.

ALRV5XR effectively promotes hair regrowth in both men and women through different mechanisms.

Low iron levels in the blood could be a sign of Telogen Effluvium, a type of hair loss, but it's not always accurate in distinguishing it from other hair loss types.

Hair loss in a child was an early sign of Crohn's disease.

Hair loss can be an early sign of Crohn's disease in children.

The document concludes that a new treatment for a type of hair loss called telogen effluvium was tested and shows promise.

Higher oxidative stress markers are linked to hair loss in post-COVID-19 patients.

Traditional Ayurvedic treatment improved hair loss in a young woman.